Clik here to view.
Pfizer Prices $1,065,000,000 Debt Offering
Friday, February 24th 2017 at 6:09pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) today announced the pricing of $1,065,000,000 aggregate principal amount of 4.20% notes due 2047. This...
View ArticleClik here to view.
Acorda to Present at the Cowen and Company 37th Annual Healthcare Conference
Monday, February 27th 2017 at 12:00pm UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) will present at the Cowen and Company 37th Annual Health Care Conference in Boston on...
View ArticleClik here to view.
Danimer Scientific and PepsiCo to Collaborate on Biodegradable Resins
Monday, February 27th 2017 at 3:15pm UTC Agreement will enable expanded production of Danimer Scientific’s NodaxTM PHA BAINBRIDGE, GA & PURCHASE, N.Y.–(BUSINESS WIRE)– Biotechnology leader Danimer...
View ArticleClik here to view.
Exelixis and Bristol-Myers Squibb Enter Clinical Collaboration for Late-Stage...
Monday, February 27th 2017 at 11:59am UTC Companies intend to initiate pivotal trial evaluating CABOMETYX™ (cabozantinib) with Opdivo® (nivolumab) alone or in combination with Yervoy® (ipilimumab) in...
View ArticleClik here to view.
Bristol-Myers Squibb to Take Part in Cowen and Company 37th Annual Global...
Monday, February 27th 2017 at 2:30pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE: BMY) will present at the Cowen and Company 37th Annual Global Health Care Conference on Monday,...
View ArticleClik here to view.
Syros Pharmaceuticals to Present at Upcoming Investor Conferences
Wednesday, March 1st 2017 at 1:01pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the...
View ArticleClik here to view.
CORRECTING and REPLACING Synergy Pharmaceuticals Reports Fourth Quarter and...
Thursday, March 2nd 2017 at 9:45pm UTC NEW YORK–(BUSINESS WIRE)– Please replace the release, dated March 1, 2017, with the following corrected version due to multiple revisions in the Financial...
View ArticleClik here to view.
Bristol-Myers Squibb Announces Dividend
Thursday, March 2nd 2017 at 9:34pm UTC NEW YORK–(BUSINESS WIRE)– The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of thirty-nine cents ($0.39) per...
View ArticleClik here to view.
Stockholders Endorse venBio’s Case for Meaningful Change at Immunomedics
Friday, March 3rd 2017 at 5:00pm UTC Preliminary Results Indicate Stockholders Have Elected ALL FOUR of venBio’s Independent, Highly-qualified Nominees NEW YORK–(BUSINESS WIRE)– venBio Select Advisor...
View ArticleClik here to view.
Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial...
Wednesday, March 1st 2017 at 9:42pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel...
View ArticleClik here to view.
Merck and Pfizer Announce U.S. FDA and EMA Filing Acceptances of Three...
Monday, March 6th 2017 at 1:00pm UTC Investigational SGLT2 Inhibitor Submitted as Monotherapy and in Fixed-Dose Combinations with JANUVIA® (sitagliptin) or Metformin KENILWORTH, N.J. & NEW...
View ArticleClik here to view.
Bristol-Myers Squibb and Pfizer to Present New Analyses of Eliquis™...
Monday, March 6th 2017 at 1:30pm UTC Post-hoc Analyses from the ARISTOTLE Trial Featured in Late-Breaker and Poster Sessions Real-World Data Analyses Include Database Reviews of U.S. Medicare Patient...
View ArticleClik here to view.
Izun Pharmaceuticals Announces Approval of Curasite™ Hydrogel Wound Care...
Monday, March 6th 2017 at 6:00am UTC Product approved for prescription and over the counter indications NEW YORK–(BUSINESS WIRE)– Izun Pharmaceuticals Corporation (“Izun”, “Company”, izunpharma.com),...
View ArticleClik here to view.
The Medicines Company to Host Conference Call and Webcast at Upcoming...
Monday, March 6th 2017 at 12:00pm UTC – Late-breaking data from ORION-1 Phase II study of inclisiran (PCSK9si) will be reviewed by the Company and members of its distinguished advisory board –...
View ArticleClik here to view.
Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2017 Results...
Monday, March 6th 2017 at 3:30pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2017 second quarter results, Tuesday, March 14, 2017, at...
View ArticleClik here to view.
Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board
Tuesday, March 7th 2017 at 9:30pm UTC New Board Members Include Hematology Experts Catherine Bollard, Hervé Dombret, Ola Landgren, Marcela Maus & Dietger Niederweiser NEW YORK–(BUSINESS WIRE)–...
View ArticleClik here to view.
Cellectis Reports 4th Quarter and Full Year 2016 Financial Results
Monday, March 6th 2017 at 9:30pm UTC FDA approval to conduct Phase I clinical trials for UCART123 in AML & BPDCN patients UCART191 Phase I clinical trials ongoing in ALL patients; partial data...
View ArticleClik here to view.
Orthopaedic Imaging at UnityPoint Health – Meriter Drives Need for Fully...
Wednesday, March 8th 2017 at 1:30pm UTC Five Mobile X-ray Systems Deliver Rapid Access to Images for ED, OR, NICU, ICU and General Radiology Patient Exams ROCHESTER, N.Y.–(BUSINESS WIRE)– UnityPoint...
View ArticleClik here to view.
Flex Pharma Reports Year End 2016 Financial Results
Wednesday, March 8th 2017 at 12:00pm UTC — IND Submission for FLX-787 On Track for H1 2017 —— Phase 2 ALS & CMT Studies with FLX-787 Planned to Initiate This Year —— Successful Launch Year for...
View ArticleClik here to view.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare...
Wednesday, March 8th 2017 at 3:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Frank D’Amelio, Executive Vice...
View Article